These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29569654)

  • 21. Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma.
    Hu J; Song C; Duan B; Zhang X; Li D; Zhu L; Gao H
    Oncotarget; 2018 Jul; 9(58):31311. PubMed ID: 30131857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction: p53 and metabolism: from mechanism to therapeutics.
    Simabuco FM; Morale MG; Pavan ICB; Morelli AP; Silva FR; Tamura RE
    Oncotarget; 2018 Sep; 9(74):34030. PubMed ID: 30338044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction: Beneficial bacteria inhibit cachexia.
    Varian BJ; Gourishetti S; Poutahidis T; Lakritz JR; Levkovich T; Kwok C; Teliousis K; Ibrahim YM; Mirabal S; Erdman SE
    Oncotarget; 2018 Jun; 9(50):29536. PubMed ID: 30034637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correction: Endonuclease G promotes mitochondrial genome cleavage and replication.
    Wiehe RS; Gole B; Chatre L; Walther P; Calzia E; Palmer A; Gebhardt JCM; Ricchetti M; Wiesmüller L
    Oncotarget; 2018 Jun; 9(45):27908. PubMed ID: 29963248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction: Dietary cholesterol intake and stroke risk: a meta-analysis.
    Cheng P; Pan J; Xia J; Huang W; Bai S; Zhu X; Shao W; Wang H; Xie P
    Oncotarget; 2018 Jun; 9(45):27907. PubMed ID: 29963247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correction: Role of novel histone modifications in cancer.
    Shanmugam MK; Arfuso F; Arumugam S; Chinnathambi A; Bian J; Warrier S; Wang LZ; Kumar AP; Ahn KS; Sethi G; Lakshmanan M
    Oncotarget; 2018 Apr; 9(27):19460. PubMed ID: 29722359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correction: Incidence and risk of regorafenib-induced hepatotoxicity.
    Zhao B; Zhao H
    Oncotarget; 2019 Jan; 10(2):253. PubMed ID: 30719219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correction: Post-pancreaticoduodenectomy hemorrhage: DSA diagnosis and endovascular treatment.
    Zhou TY; Sun JH; Zhang YL; Zhou GH; Nie CH; Zhu TY; Chen SQ; Wang BQ; Wang WL; Zheng SS
    Oncotarget; 2018 Mar; 9(20):15436. PubMed ID: 29634045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction: The role of substance P in epilepsy and seizure disorders.
    Wang XF; Ge TT; Fan J; Yang W; Li B; Cui RJ
    Oncotarget; 2019 May; 10(37):3576. PubMed ID: 31191827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction: Molecular response prediction in CML: novel ideas?
    Wolf D; Sopper S
    Oncotarget; 2018 Nov; 9(88):35871. PubMed ID: 30533202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib.
    Zhao B; Zhao H
    Oncotarget; 2019 Jan; 10(2):254. PubMed ID: 30719220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction: Antibody targeting TSPAN12/β-catenin signaling in vasoproliferative retinopathy.
    Bucher F; Friedlander M; Yea K
    Oncotarget; 2018 Sep; 9(69):33244. PubMed ID: 30237865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.
    Nivarthi H; Gordziel C; Themanns M; Kramer N; Eberl M; Rabe B; Schlederer M; Rose-John S; Knösel T; Kenner L; Freund P; Aberger F; Han X; Kralovics R; Dolznig H; Jennek S; Friedrich K; Moriggl R
    Oncotarget; 2018 Sep; 9(73):33865. PubMed ID: 30333916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.
    Ladju RB; Pascut D; Massi MN; Tiribelli C; Sukowati CHC
    Oncotarget; 2018 Feb; 9(16):13101. PubMed ID: 29569656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: Posttranscriptional regulation of Galectin-3 by miR-128 contributes to colorectal cancer progression.
    Lu W; Wang J; Yang G; Yu N; Huang Z; Xu H; Li J; Qiu J; Zeng X; Chen S; Li N; Liu H
    Oncotarget; 2018 Feb; 9(15):12535. PubMed ID: 29552332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.
    Lin CY; Hsieh PL; Liao YW; Peng CY; Lu MY; Yang CH; Yu CC; Liu CM
    Oncotarget; 2018 May; 9(37):24870. PubMed ID: 29873328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction: MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
    An F; Gong G; Wang Y; Bian M; Yu L; Wei C
    Oncotarget; 2018 May; 9(37):24871. PubMed ID: 29873327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correction: Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel.
    Park J; Choi Y; Namkung J; Yi SG; Kim H; Yu J; Kim Y; Kwon MS; Kwon W; Oh DY; Kim SW; Jeong SY; Han W; Lee KE; Heo JS; Park JO; Park JK; Kim SC; Kang CM; Lee WJ; Lee S; Han S; Park T; Jang JY; Kim Y
    Oncotarget; 2018 Jan; 9(4):5514. PubMed ID: 29436532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction: Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis.
    Fu S; Wen X; Han F; Long Y; Xu G
    Oncotarget; 2018 Jan; 9(5):6658. PubMed ID: 29465717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction: Efficacy of transcatheter arterial chemoembolization for liver metastases arising from pancreatic cancer.
    Sun JH; Zhou TY; Zhang YL; Zhou GH; Nie CH; Zhu TY; Chen SQ; Wang BQ; Ye S; Shen Y; Guo H; Wang WL; Zheng SS
    Oncotarget; 2018 Mar; 9(20):15435. PubMed ID: 29632656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.